European Prostate Cancer Diagnostic and Therapeutic Market Dynamics, Trends, Opportunities, Drivers, Challenges and Forecast 2025

European prostate cancer market is expected to grow at a CAGR of 10.8% during the forecast period. The high prevalence of prostate cancer in the region is one of the major factors for the demand for prostate cancer diagnostics and therapeutics market. As per the World Health Organization, in Europe, around 450,000 new cases of prostate cancer were registered in 2018 in the region. Europe caters around 35% of the global prostate cancer cases, which is highest all across the globe. Moreover, the adoption of innovative technologies for the diagnosis of prostate cancer such as biomarkers and the adoption of personalized medicine for treatment is expected to provide a significant opportunity to the market.

Get Sample Copy of European Prostate Cancer Diagnostic and Therapeutic Market at: https://www.omrglobal.com/request-sample/european-prostate-cancer-diagnostic-therapeutic-market

The companies which are contributing significantly in the market include Abbott Laboratories, AbbVie Products, LLC, Amgen Inc., Ferring Pharmaceuticals Inc., Johnson & Johnson, Siemens Healthcare AG, Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., and others.

European prostate cancer diagnostic and therapeutic market has been studied on the basis of diagnostic techniques and therapeutics. By diagnostic technique, the market is segmented into prostate-specific antigen test, digital rectal examination, prostate biopsy, imaging techniques. Prostate biopsy is expected to hold a major market share during the forecast period. By therapeutics, the market is segmented into hormonal therapy, chemotherapy, immunotherapy, radiation therapy, targeted therapy, surgery. During the forecast period, chemotherapy is expected to have a major market share in the region.

For More Information, get A full report of European Prostate Cancer Diagnostic and Therapeutic is available at: https://www.omrglobal.com/industry-reports/european-prostate-cancer-diagnostic-therapeutic-market

Geographically, the market is divided into Germany, France, UK, Spain, Italy and the Rest of Europe. France and Germany are expected to have a major market share during the forecast period. Around 65,000 new cases in France whereas in Germany around 63,000 new cases of prostate cancer were registered in 2018. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
European Prostate Cancer Diagnostic and Therapeutic Market Segmentation

European Prostate Cancer Diagnostic and Therapeutic Market by Diagnostic Techniques

o Prostate-Specific Antigen Test (PSA)
o Digital Rectal Examination
o Prostate Biopsy
o Imaging Techniques

European Prostate Cancer Diagnostic and Therapeutic Market by Therapeutics

o Hormonal Therapy
o Chemotherapy
o Immunotherapy
o Radiation Therapy
o Targeted Therapy
o Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-prostate-cancer-diagnostic-therapeutic-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.